Nov 4, 2019

Emergency medication

Medication needs of cancer patients are very broad.  Not only do they include chemotherapy medications, but also medicine to treat side effects, to prevent complications, to increase blood counts, and many others.  Among them, are antiviral drugs. 

Cancer patients recovering from toxicities associated with chemotherapy and other treatments are often vulnerable to infections, and suffer more severe illness as a result of infection.  Antiviral drugs, just like antibiotics and antifungals, are essential for protection of cancer patients during their lengthy treatment process.  Most recently, we have used your donations to purchase medications to support cancer patients needing intensive care. 

Foscavir is a medication that treats viral infections - usually herpes viruses, such as herpes simplex and drug-resistant CMV.  Often, it's the last resort drug used in intensive care units.  Although it has been available since 1990s, it is not registered in Russia. For that reason, the hospitals are unable to acquire it and have to ask charities for help with making it available for gravely sick patients.  The medication has to be on hand, because once the infection spirals out of control, it is a matter of days, and sometimes hours, before it becomes lethal. 

Thanks to your support, we were able to pay $2,700 towards the costs of acquiring Foscavir for hospitals in St. Petersburg in August, and we anticipate another bill soon.   Thank you so much for helping us support cancer patients with this vital medication and save lives! 

Happy upcoming holiday season to you!  Stay warm! 

Oct 10, 2019

How we are doing


It's hard to believe, but we are already in October, and before we know it, the holiday season will be here!  As temperatures cool, we are starting to take preliminary account of our results this year.  We are happy to report that in 2019, our program to help leukemia patients afford bone marrow donor searches has seen an increase in donations, with almost $75,000 spent to date to support 13 patients. 

We are proud of your trust in us and dedication to our cause!   Bone marrow transplants are the only chance for cure for many leukemia patients.  Your support makes it possible and literally makes life or death difference for the patients.  Thank you so much! 

Our latest support recipient is a 23-year old Violetta from a village in Rostov region.  After she graduated from college, Violetta moved to a city, Rostov-on-Don, and studied to become an accountant.  Only two years into her career, Violetta became ill - she started having persistent nosebleeds and  stomachaches, and became fatigued.  The tests showed Violetta had blood abnormalities and an enlarged spleen, and she was diagnosed with chronic myeloid leukemia.  Although many patients like her are able to stay on oral medication for many years, Violetta developed complications and severe side effects to standard therapy.  In June she was moved to a third-line drug, but it was uncertain how long she would be able to tolerate the treatment.  For this reason, she was referred for bone marrow transplantation that could be curative in her case.  On October 1st Violetta underwent transplantation from an unrelated donor that was found in Germany.  She is now recovering and feeling relatively well overall. 

Thanks again for supporting Violetta and patients like her!  Wishing you a happy and bountiful fall season! 

Sep 17, 2019

Anastasia needs our help!


Anastasia's story is very similar to those of other kids like her whose families applied for help this year. It happens like this: a new medication becomes available in the US and Europe and gives hope to the patients who previously would have been denied further treatment.  However, for various reasons it takes several years before the medication becomes approved and registered in the former Soviet Union countries.  Meanwhile, doctors and patient communities begin looking for ways to access better treatments.  Often families with sick kids travel to other countries where the medicine is already available and doctors have experience treating patients with it. 

Anastasia is one of those kids.  She is 10 years old and loves animals - horses, in particular.  She has been drawing them since she was little.  In January 2017 Anastasia was diagnosed with acute lymphoblastic leukemia. Initial treatment took almost a year.  Anastasia was treated in a regional cancer hospital in Vladivostok, in Russia’s Far East.  Unfortunately, just two weeks after returning home she started having pains in her legs – it turned out to be a symptom of disease recurrence.  Anastasia’s family flew her across Russia to Moscow.  There, in May 2018, she underwent a risky, but often effective procedure: bone marrow transplant from an unrelated donor.  Unfortunately, in just 90 days Anastasia had another relapse.   She then proceeded to have CAR-T cell therapy that worked for 160 days, but then yet again Anastasia relapsed.  At that point she exhausted all treatment options available in Russia. 

Anastasia’s parents heard about new drugs recently approved for leukemia.  They brought her to Seoul, South Korea for evaluation and a second opinion.  The doctors there recommended therapy with inotuzumab, a new medication that can work even in heavily pre-treated patients.  They are hoping to give Anastasia one last chance to beat leukemia.  The treatment with this new drug is very expensive, and Anastasia’s family is raising funds to afford therapy.

Thank you for your support for this project and patients like Anastasia!  Your help allows them to access new medications without delay and improve their chances to beat cancer.  We truly appreciate your kindness!

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.